(Q68055554)
Statements
Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production (English)
Cheever AW
Finkelman FD
Caspar P
Heiny S
Macedonia JG